Cargando…

Commentary: Why we should report results from clinical trial pilot studies

Detalles Bibliográficos
Autor principal:	Friedman, Lawrence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599527/ https://www.ncbi.nlm.nih.gov/pubmed/23305191 http://dx.doi.org/10.1186/1745-6215-14-14

Ejemplares similares

Commentary: Why should we classify damage control in cardiac surgery?
por: Haaverstad, Rune, et al.
Publicado: (2021)

Why We should Assess Patients’ Expectations in Clinical Trials
por: Frisaldi, Elisa, et al.
Publicado: (2017)

Commentary: Pleurography: We can, but should we?
por: Benz, Cecilia, et al.
Publicado: (2021)

Commentary: Coronary revascularization: How should we do it?
por: Sotolongo, Alex, et al.
Publicado: (2020)

Commentary: Ocular lesions in leprosy – Should we forget?
por: Biswas, Jyotirmay, et al.
Publicado: (2022)

Novel Forms of Lipodystrophy: Why should we care?
por: Rother, Kristina I., et al.
Publicado: (2013)

Commentary: Just because we can, doesn't always mean we should
por: Nellis, Joseph R., et al.
Publicado: (2021)

Commentary: Should we freeze the elephant trunk with or without stents?
por: Dagenais, François
Publicado: (2020)

Enhancement drugs: are there limits to what we should enhance and why?
por: Hesse, Morten
Publicado: (2010)

Commentary: Should we book a seat on the aortic neocuspidization rocket?
por: Baciewicz, Frank A.
Publicado: (2021)

Commentary: Aortic root enlargement: Just because we can, does that mean we should?
por: Lau, Christopher, et al.
Publicado: (2020)

Ventilator-induced lung injury and mechanotransduction: why should we care?
por: Liu, Mingyao
Publicado: (2007)

Why should we not use APACHE II for performance measurement and benchmarking?
por: Soares, Marcio, et al.
Publicado: (2017)

Global access of rifabutin for the treatment of tuberculosis – why should we prioritize this?
por: Rockwood, Neesha, et al.
Publicado: (2019)

Commentary: we can tell where it hurts, but can we tell where the pain is coming from or where we should manipulate?
por: Brady, O’Dane, et al.
Publicado: (2013)

Acne Scarring: Why We Should Act Sooner Rather Than Later
por: Dréno, Brigitte, et al.
Publicado: (2021)

Why We Should Consider Evidence-Based Treatment Options for Truncal Acne
por: Stein Gold, Linda, et al.
Publicado: (2021)

The impact of public involvement in health research: what are we measuring? Why are we measuring it? Should we stop measuring it?
por: Russell, Jill, et al.
Publicado: (2020)

Medical marijuana programs — Why might they matter for public health and why should we better understand their impacts?
por: Fischer, Benedikt, et al.
Publicado: (2015)

Why we should raise stroke awareness in the younger population?
por: Zhao, Jing, et al.
Publicado: (2023)

Commentary: Patient Perspectives on Artificial Intelligence; What have We Learned and How Should We Move Forward?
por: Camaradou, Jennifer Catherine Louise, et al.
Publicado: (2023)

Commentary: That's all folks! But what should we really do to repair the aortic valve?
por: Weltert, Luca, et al.
Publicado: (2021)

Why we should never do it: stigma as a behaviour change tool in global health
por: Brewis, Alexandra, et al.
Publicado: (2019)

Why should we care about fly tumors?: The case of JAK-STAT and EGFR cooperation in oncogenesis
por: Hombría, James Castelli-Gair, et al.
Publicado: (2013)

Health promotion for children, mothers and families: here’s why we should “think about it before conception”
por: Corchia, Carlo, et al.
Publicado: (2013)

Commentary: Tricuspid repair—why the hesitation?
por: Nafday, Heidi B., et al.
Publicado: (2020)

Why we need easy access to all data from all clinical trials and how to accomplish it
por: Gøtzsche, Peter C
Publicado: (2011)

Commentary: Because we can
por: Hanna, Waël C.
Publicado: (2020)

Why prudence is needed when interpreting articles reporting clinical trial results in mental health
por: Dal-Ré, Rafael, et al.
Publicado: (2017)

Commentary on the clinical management of metabolic syndrome: why a healthy lifestyle is important
por: de Lorgeril, Michel
Publicado: (2012)

Why We Should Bathe
Publicado: (1888)

Commentary: Neighbors should keep their distance after esophagectomy
por: Nava, Ruben G., et al.
Publicado: (2021)

Commentary: The Ross reversal: Should it be done, if so when?
por: Mack, Charles A., et al.
Publicado: (2021)

Should we modulate the neonatal microbiome and what should be the goal?
por: van Best, Niels, et al.
Publicado: (2022)

Rethinking clinical study data: why we should respect analysis results as data
por: Barros, Joana M., et al.
Publicado: (2022)

The signed Kolmogorov-Smirnov test: why it should not be used
por: Filion, Guillaume J
Publicado: (2015)

Should we abandon indirect calorimetry as a tool to diagnose energy expenditure? Not yet. Perhaps not ever. Commentary on Burnett and Grobe (2014)
por: Speakman, John R.
Publicado: (2014)

Commentary: Retinoblastoma management—Where are we and where do we go from here?
por: Shanmugam, P Mahesh
Publicado: (2020)

Should we breathe quiet or noisy?
por: Putensen, Christian, et al.
Publicado: (2014)

Critical incident reporting: Why should we bother?
por: Tewari, Anurag, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_j3kdirpj895eataohjdc5323ec